DE60335139D1 - Virusähnliche partikel, verfahren zur herstellung und immunogene zusammensetzungen - Google Patents
Virusähnliche partikel, verfahren zur herstellung und immunogene zusammensetzungenInfo
- Publication number
- DE60335139D1 DE60335139D1 DE60335139T DE60335139T DE60335139D1 DE 60335139 D1 DE60335139 D1 DE 60335139D1 DE 60335139 T DE60335139 T DE 60335139T DE 60335139 T DE60335139 T DE 60335139T DE 60335139 D1 DE60335139 D1 DE 60335139D1
- Authority
- DE
- Germany
- Prior art keywords
- vlp
- particles
- viral
- virus
- immunogenic compositions
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5258—Virus-like particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55516—Proteins; Peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/10023—Virus like particles [VLP]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
- C12N2740/15023—Virus like particles [VLP]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16023—Virus like particles [VLP]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2810/00—Vectors comprising a targeting moiety
- C12N2810/50—Vectors comprising as targeting moiety peptide derived from defined protein
- C12N2810/60—Vectors comprising as targeting moiety peptide derived from defined protein from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2810/00—Vectors comprising a targeting moiety
- C12N2810/50—Vectors comprising as targeting moiety peptide derived from defined protein
- C12N2810/60—Vectors comprising as targeting moiety peptide derived from defined protein from viruses
- C12N2810/6045—RNA rev transcr viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2810/00—Vectors comprising a targeting moiety
- C12N2810/50—Vectors comprising as targeting moiety peptide derived from defined protein
- C12N2810/60—Vectors comprising as targeting moiety peptide derived from defined protein from viruses
- C12N2810/6072—Vectors comprising as targeting moiety peptide derived from defined protein from viruses negative strand RNA viruses
- C12N2810/6081—Vectors comprising as targeting moiety peptide derived from defined protein from viruses negative strand RNA viruses rhabdoviridae, e.g. VSV
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Virology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US38155702P | 2002-05-17 | 2002-05-17 | |
US45413903P | 2003-03-11 | 2003-03-11 | |
US45411503P | 2003-03-11 | 2003-03-11 | |
US45458403P | 2003-03-14 | 2003-03-14 | |
US46831803P | 2003-05-06 | 2003-05-06 | |
US47124603P | 2003-05-16 | 2003-05-16 | |
PCT/US2003/015930 WO2004042001A2 (en) | 2002-05-17 | 2003-05-19 | Virus-like particles, methods of preparation, and immonogenic compositions |
Publications (1)
Publication Number | Publication Date |
---|---|
DE60335139D1 true DE60335139D1 (de) | 2011-01-05 |
Family
ID=34199380
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60335139T Expired - Lifetime DE60335139D1 (de) | 2002-05-17 | 2003-05-19 | Virusähnliche partikel, verfahren zur herstellung und immunogene zusammensetzungen |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1576143B1 (de) |
AT (1) | ATE489106T1 (de) |
AU (1) | AU2003301844A1 (de) |
CA (1) | CA2486282C (de) |
DE (1) | DE60335139D1 (de) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2734118C2 (ru) * | 2015-07-02 | 2020-10-13 | Медиджен, Инк. | Рекомбинантные вирусоподобные частицы (vlp) с использованием протеина группового антигена (gag) вируса бычьего иммунодефицита |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2007345768B2 (en) * | 2006-07-27 | 2013-08-01 | Ligocyte Pharmaceuticals, Inc. | Chimeric influenza virus-like particles |
CN116024269B (zh) * | 2022-11-18 | 2024-02-02 | 复百澳(苏州)生物医药科技有限公司 | 一种冠状病毒假病毒颗粒的制备方法 |
-
2003
- 2003-05-19 DE DE60335139T patent/DE60335139D1/de not_active Expired - Lifetime
- 2003-05-19 AT AT03808386T patent/ATE489106T1/de not_active IP Right Cessation
- 2003-05-19 EP EP03808386A patent/EP1576143B1/de not_active Expired - Lifetime
- 2003-05-19 CA CA2486282A patent/CA2486282C/en not_active Expired - Fee Related
- 2003-05-19 AU AU2003301844A patent/AU2003301844A1/en not_active Abandoned
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2734118C2 (ru) * | 2015-07-02 | 2020-10-13 | Медиджен, Инк. | Рекомбинантные вирусоподобные частицы (vlp) с использованием протеина группового антигена (gag) вируса бычьего иммунодефицита |
RU2757723C2 (ru) * | 2015-07-02 | 2021-10-21 | Медиджен, Инк. | Рекомбинантные вирусоподобные частицы (vlp) с использованием протеина группового антигена (gag) вируса бычьего иммунодефицита |
Also Published As
Publication number | Publication date |
---|---|
EP1576143A4 (de) | 2007-08-08 |
AU2003301844A1 (en) | 2004-06-07 |
EP1576143B1 (de) | 2010-11-24 |
EP1576143A2 (de) | 2005-09-21 |
ATE489106T1 (de) | 2010-12-15 |
CA2486282A1 (en) | 2004-05-21 |
CA2486282C (en) | 2012-04-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2004042001A3 (en) | Virus-like particles, methods of preparation, and immonogenic compositions | |
WO2000032227A3 (en) | Ordered molecular presentation of antigens, method of preparation and use | |
WO2007019247A3 (en) | Virus-like particles as vaccines for paramyxovirus | |
NO20050396L (no) | Adjuvant viral partikkel | |
NO20063157L (no) | Influensa-immunogen og vaksine | |
JP2009501001A5 (de) | ||
WO2001098333A3 (en) | Modification of hepatitis b core antigen | |
DE69535018D1 (de) | Papillomavirus vakzine | |
WO2003077942A3 (en) | Virus-like particles of human papillomavirus | |
ATE373721T1 (de) | Verpackung von replikon-partikeln eines positiv- strängigen rna-virus | |
EP2290091A3 (de) | Rekombinante Masernviren, welche Epitope der Antigene von RNA-Viren exprimieren, sowie die Verwendung der rekombinanten Viren zur Herstellung von Impfstoffen | |
WO2008148104A8 (en) | Novel vlps derived from cells that do not express a viral matrix or core protein | |
ATE516345T1 (de) | Von ibdv (infectious bursal disease virus) abgeleitete chimäre leere virusähnliche partikel, verfahren zu deren herstellung und anwendungen | |
EP0877086A3 (de) | Aus infektiösem cDNS eingetriebene rekombinate YF Viren-Impfstoffe | |
WO2006045532A3 (en) | Virosome particles comprising antigens from influenza virus and hepatitis b virus | |
WO2007046839A3 (en) | New live virus vaccines | |
MXPA02012593A (es) | Particulas de tipo virus del virus de la diarrea viral bovina. | |
WO2003031583A3 (en) | Generation of virus-like particles by vsv | |
WO2005011571A3 (en) | Hepatitis virus core proteins as vaccine platforms and methods of use thereof | |
DE60335139D1 (de) | Virusähnliche partikel, verfahren zur herstellung und immunogene zusammensetzungen | |
DE60222296D1 (de) | Impfstoff von umhüllten viren und verfahren zu seiner herstellung | |
WO2005108560A3 (en) | Synthesis and purification of west nile virus virus-like particles | |
ATE427119T1 (de) | Rekombinante tollwut-vakzine und verfahren zu ihrer herstellung und verwendung | |
WO2019178288A3 (en) | Virus-like nanocapsid for oral delivery of insulin | |
WO2001027282A8 (en) | Plant virus particles with exogenous internal eitopes |